Sign in

CIK 0001737953

  • Non-accelerated filer
  • Smaller reporting company

Replimune Group, Inc.

Sign in to watch
Ticker
REPL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
822082553
Phone
+1 781-222-9600
Business address
500 UNICORN PARK, WOBURN, MA, 01801
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$521,860
in 2 filings

Net −$521,860. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Dhingra Kapil −$409K Director sold 50% of stake
  2. SLATTERY JOSEPH P −$113K Director sold 78% of stake

Reading 83 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-01-15 Love Colin Chief Operating Officer Sale −12,396 $43.07 $534K 954,381
2021-01-15 Omega Fund IV, L.P. Director Sale −1,916 $45.19 $87K 5,325,391
2021-01-14 Esposito Pamela Chief Business Officer Option exercise +20,000 $1.01 $20K 195,994
2021-01-14 Esposito Pamela Chief Business Officer Sale −20,000 $45.02 $900K 175,994
2021-01-14 Esposito Pamela Chief Business Officer Option exercise · Employee Stock Option (right to buy) −20,000 108,203
2021-01-14 Astley-Sparke Philip Chief Executive Officer Sale −17,452 $44.78 $782K 1,287,845
2021-01-14 Astley-Sparke Philip Chief Executive Officer Sale −7,448 $43.61 $325K 1,280,397
2021-01-14 Astley-Sparke Philip Chief Executive Officer Sale −100 $43.06 $4K 1,280,297
2021-01-14 Esposito Pamela Chief Business Officer Option exercise +20,000 $1.01 $20K 195,994
2021-01-14 Esposito Pamela Chief Business Officer Sale −20,000 $45.02 $900K 175,994
2021-01-14 Esposito Pamela Chief Business Officer Option exercise · Employee Stock Option (right to buy) −20,000 108,203
2021-01-14 Omega Fund IV, L.P. Director Sale −17,664 $45.09 $796K 5,327,307
2021-01-14 Franchi Jean M. Chief Financial Officer Option exercise +14,900 $14.08 $210K 14,900
2021-01-14 Franchi Jean M. Chief Financial Officer Sale −14,300 $44.55 $637K 600
2021-01-14 Franchi Jean M. Chief Financial Officer Sale −600 $44.00 $26K 0
2021-01-14 Franchi Jean M. Chief Financial Officer Option exercise · Employee Stock Option (right to buy) −14,900 140,000
2021-01-13 Franchi Jean M. Chief Financial Officer Option exercise +100 $14.08 $1K 100
2021-01-13 Franchi Jean M. Chief Financial Officer Sale −100 $44.19 $4K 0
2021-01-13 Franchi Jean M. Chief Financial Officer Option exercise · Employee Stock Option (right to buy) −100 154,900
2020-12-23 Esposito Pamela Chief Business Officer Option exercise +50,704 $1.75 $89K 175,994

Page 17 of 19 · 365 trades